Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MTOB (α-keto-γ-Methylthiobutyric acid) is a substrate for c-terminal binding protein (CtBP) that interferes with the carcinogenic activity of CtBP in cell culture and mice. It also actively regulates TCF-4 signaling, leading to cancer stem cell (CSC) growth and self-renewal.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 75.00 | |
5 mg | In stock | $ 111.00 | |
10 mg | In stock | $ 153.00 | |
25 mg | In stock | Inquiry | |
50 mg | In stock | Inquiry |
Description | MTOB (α-keto-γ-Methylthiobutyric acid) is a substrate for c-terminal binding protein (CtBP) that interferes with the carcinogenic activity of CtBP in cell culture and mice. It also actively regulates TCF-4 signaling, leading to cancer stem cell (CSC) growth and self-renewal. |
Synonyms | α-keto-γ-Methylthiobutyric acid, KMBA, MTOB salt, 4-methylthio 2-oxobutyric acid |
Molecular Weight | 170.16 |
Formula | C5H7NaO3S |
CAS No. | 51828-97-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS: 100 mg/mL (587.68 mM), Sonication is recommended.
DMSO: 55 mg/mL (323.23 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MTOB 51828-97-8 Others alpha-keto-gamma-Methylthiobutyric acid CtBP MCF-7 α-keto-γ-Methylthiobutyric acid breast cancer traumatic brain injury inhibit KMBA MTOB salt Inhibitor a-keto-r-Methylthiobutyric acid neuroinflammation 4-methylthio 2-oxobutyric acid TBI inhibitor